Document is current
Any future updates will be listed below
-
Authors
DiMauro, Kimberly A. https://orcid.org/0009-0009-1827-1937
Thompson, Nicolas R. https://orcid.org/0000-0002-8973-5219
Lapin, Brittany https://orcid.org/0000-0002-4314-2282
Pennell, Nathan A. https://orcid.org/0000-0002-1458-0064
Stevens, Glen
Shook, Steven https://orcid.org/0000-0001-7244-6878
Cohen, Jeffrey A. https://orcid.org/0000-0001-9245-9772
Kunchok, Amy https://orcid.org/0000-0002-8387-6491
- License Information
-
More Information
Article History
Received: 20 October 2025
Revised: 29 April 2026
Accepted: 10 May 2026
First Online: 3 June 2026
Declarations
:
: Kimberly DiMauro, Nicolas Thompson, Brittany Lapin report no disclosures. Nathan A. Pennell reports compensation from consulting/advisory for Sanofi Genzyme, Bayer, Summit Therapeutics, Nuvation Bio, Genentech, BMS, Takeda, Johnson and Johnson, Eli Lilly, Iovance, and Daiichi Sankyo. Jeffrey A. Cohen reports personal compensation for consulting for Astoria, Atara, Biogen, Bristol-Myers Squibb, Convelo, and Viatris. Amy Kunchok receives compensation as an editor of Neurology Open Access.
